AU2019397401A1

AU2019397401A1 - Engineered tyrosine ammonia lyase

Engineered tyrosine ammonia lyase Download PDF

Info

Publication number: AU2019397401A1
Authority: AU; Australia
Prior art keywords: ammonia lyase; tyrosine ammonia; seq; recombinant; positions
Prior art date: 2018-12-14
Legal status : Abandoned

Application number

AU2019397401A

Other languages

English (en)

Inventor

Nikki DELLAS

Stephan JENNE

Joyce Liu

Current Assignee

Codexis Inc

Original Assignee

Codexis Inc

Priority date

2018-12-14

Filing date

2019-12-06

Publication date

2021-06-17

2019-12-06 Application filed by Codexis Inc filed Critical Codexis Inc

2021-06-17 Publication of AU2019397401A1 publication Critical patent/AU2019397401A1/en

Status Abandoned legal-status Critical Current

Links

108010052982 Tyrosine 2,3-aminomutase Proteins 0.000 title claims abstract description 482
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 238
229920001184 polypeptide Polymers 0.000 claims abstract description 233
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 233
238000000034 method Methods 0.000 claims abstract description 97
239000000203 mixture Substances 0.000 claims abstract description 79
230000002378 acidificating effect Effects 0.000 claims abstract description 68
230000035945 sensitivity Effects 0.000 claims abstract description 22
230000017854 proteolysis Effects 0.000 claims abstract description 18
230000003197 catalytic effect Effects 0.000 claims abstract description 10
238000006467 substitution reaction Methods 0.000 claims description 138
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 101
229960004441 tyrosine Drugs 0.000 claims description 92
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 87
239000002157 polynucleotide Substances 0.000 claims description 83
102000040430 polynucleotide Human genes 0.000 claims description 82
108091033319 polynucleotide Proteins 0.000 claims description 82
108091005804 Peptidases Proteins 0.000 claims description 81
239000004365 Protease Substances 0.000 claims description 77
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 70
150000001413 amino acids Chemical group 0.000 claims description 63
239000008194 pharmaceutical composition Substances 0.000 claims description 37
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 34
201000011296 tyrosinemia Diseases 0.000 claims description 33
239000013604 expression vector Substances 0.000 claims description 29
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 29
108090000317 Chymotrypsin Proteins 0.000 claims description 24
108090000631 Trypsin Proteins 0.000 claims description 24
102000004142 Trypsin Human genes 0.000 claims description 24
229960002376 chymotrypsin Drugs 0.000 claims description 24
239000012588 trypsin Substances 0.000 claims description 24
239000000758 substrate Substances 0.000 claims description 22
230000002829 reductive effect Effects 0.000 claims description 21
208000024891 symptom Diseases 0.000 claims description 19
206010001689 alkaptonuria Diseases 0.000 claims description 17
239000012634 fragment Substances 0.000 claims description 17
238000004519 manufacturing process Methods 0.000 claims description 17
238000011282 treatment Methods 0.000 claims description 15
239000002253 acid Substances 0.000 claims description 14
OUBCNLGXQFSTLU-UHFFFAOYSA-N nitisinone Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1C(=O)CCCC1=O OUBCNLGXQFSTLU-UHFFFAOYSA-N 0.000 claims description 14
229960001721 nitisinone Drugs 0.000 claims description 13
230000002776 aggregation Effects 0.000 claims description 11
238000004220 aggregation Methods 0.000 claims description 11
239000002775 capsule Substances 0.000 claims description 8
239000006187 pill Substances 0.000 claims description 8
239000003826 tablet Substances 0.000 claims description 8
239000002702 enteric coating Substances 0.000 claims description 7
238000009505 enteric coating Methods 0.000 claims description 7
239000007897 gelcap Substances 0.000 claims description 7
101710197207 2-iminoacetate synthase Proteins 0.000 claims description 6
238000012258 culturing Methods 0.000 claims description 6
230000003247 decreasing effect Effects 0.000 claims description 6
235000005911 diet Nutrition 0.000 claims description 6
230000037213 diet Effects 0.000 claims description 6
239000000546 pharmaceutical excipient Substances 0.000 claims description 6
238000002347 injection Methods 0.000 claims description 5
239000007924 injection Substances 0.000 claims description 5
239000007788 liquid Substances 0.000 claims description 5
239000000839 emulsion Substances 0.000 claims description 4
210000001035 gastrointestinal tract Anatomy 0.000 claims description 4
230000005847 immunogenicity Effects 0.000 claims description 4
150000008553 L-tyrosines Chemical class 0.000 claims description 3
108010067372 Pancreatic elastase Proteins 0.000 claims description 3
102000016387 Pancreatic elastase Human genes 0.000 claims description 3
239000003937 drug carrier Substances 0.000 claims description 3
102000005367 Carboxypeptidases Human genes 0.000 claims description 2
108010006303 Carboxypeptidases Proteins 0.000 claims description 2
230000001668 ameliorated effect Effects 0.000 claims description 2
230000001747 exhibiting effect Effects 0.000 claims description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
230000001225 therapeutic effect Effects 0.000 abstract description 6
230000000694 effects Effects 0.000 description 189
102220568027 Merlin_L46R_mutation Human genes 0.000 description 127
102200038284 rs28941776 Human genes 0.000 description 114
239000006166 lysate Substances 0.000 description 109
235000001014 amino acid Nutrition 0.000 description 108
210000004027 cell Anatomy 0.000 description 108
102220114657 rs886038944 Human genes 0.000 description 106
125000003275 alpha amino acid group Chemical group 0.000 description 85
238000003556 assay Methods 0.000 description 83
102000035195 Peptidases Human genes 0.000 description 79
102220626670 Electrogenic sodium bicarbonate cotransporter 1_T49D_mutation Human genes 0.000 description 74
235000019419 proteases Nutrition 0.000 description 71
108090000623 proteins and genes Proteins 0.000 description 71
229940024606 amino acid Drugs 0.000 description 69
102220532122 39S ribosomal protein L4, mitochondrial_S59A_mutation Human genes 0.000 description 61
102000004190 Enzymes Human genes 0.000 description 56
108090000790 Enzymes Proteins 0.000 description 56
229940088598 enzyme Drugs 0.000 description 56
239000000872 buffer Substances 0.000 description 55
238000004458 analytical method Methods 0.000 description 43
102220074662 rs757922781 Human genes 0.000 description 42
125000000539 amino acid group Chemical group 0.000 description 32
238000006243 chemical reaction Methods 0.000 description 31
102220249027 rs1174073920 Human genes 0.000 description 31
239000001488 sodium phosphate Substances 0.000 description 29
229910000162 sodium phosphate Inorganic materials 0.000 description 29
235000011008 sodium phosphates Nutrition 0.000 description 29
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 29
150000007523 nucleic acids Chemical class 0.000 description 28
102000004169 proteins and genes Human genes 0.000 description 28
230000014509 gene expression Effects 0.000 description 27
241000588724 Escherichia coli Species 0.000 description 26
235000018102 proteins Nutrition 0.000 description 26
240000004808 Saccharomyces cerevisiae Species 0.000 description 23
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 23
238000002835 absorbance Methods 0.000 description 23
108091026890 Coding region Proteins 0.000 description 22
230000002255 enzymatic effect Effects 0.000 description 20
230000012010 growth Effects 0.000 description 20
239000013598 vector Substances 0.000 description 20
102220232849 rs1085307991 Human genes 0.000 description 19
102220044402 rs61756469 Human genes 0.000 description 19
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
102220511091 APC membrane recruitment protein 1_K44R_mutation Human genes 0.000 description 18
102220094198 rs759589301 Human genes 0.000 description 18
102220023566 rs397514996 Human genes 0.000 description 17
230000009089 cytolysis Effects 0.000 description 16
238000002474 experimental method Methods 0.000 description 16
102000039446 nucleic acids Human genes 0.000 description 16
108020004707 nucleic acids Proteins 0.000 description 16
108020004705 Codon Proteins 0.000 description 15
108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 15
108010076504 Protein Sorting Signals Proteins 0.000 description 15
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
102220084572 rs863225027 Human genes 0.000 description 15
238000012216 screening Methods 0.000 description 15
239000000243 solution Substances 0.000 description 15
108091028043 Nucleic acid sequence Proteins 0.000 description 14
150000001875 compounds Chemical class 0.000 description 14
201000010099 disease Diseases 0.000 description 14
239000000047 product Substances 0.000 description 14
102220574639 ATP-citrate synthase_K554Q_mutation Human genes 0.000 description 13
238000012217 deletion Methods 0.000 description 13
230000037430 deletion Effects 0.000 description 13
102220199342 rs1057521133 Human genes 0.000 description 13
102220638987 Beta-enolase_H16Q_mutation Human genes 0.000 description 12
102220297573 rs368094683 Human genes 0.000 description 12
241000894007 species Species 0.000 description 12
102000053602 DNA Human genes 0.000 description 11
108020004414 DNA Proteins 0.000 description 11
102220517445 Denticleless protein homolog_T90S_mutation Human genes 0.000 description 11
102220064269 rs786205766 Human genes 0.000 description 11
102220510683 APC membrane recruitment protein 1_D20G_mutation Human genes 0.000 description 10
241001465754 Metazoa Species 0.000 description 10
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
102220580925 Voltage-dependent T-type calcium channel subunit alpha-1H_V57I_mutation Human genes 0.000 description 10
-1 aliphatic amino acid Chemical class 0.000 description 10
238000009396 hybridization Methods 0.000 description 10
238000011534 incubation Methods 0.000 description 10
238000003780 insertion Methods 0.000 description 10
230000037431 insertion Effects 0.000 description 10
239000006228 supernatant Substances 0.000 description 10
238000009472 formulation Methods 0.000 description 9
238000002703 mutagenesis Methods 0.000 description 9
231100000350 mutagenesis Toxicity 0.000 description 9
239000000843 powder Substances 0.000 description 9
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 9
102220099511 rs746635262 Human genes 0.000 description 9
238000013518 transcription Methods 0.000 description 9
230000035897 transcription Effects 0.000 description 9
102220486475 Mannose-1-phosphate guanyltransferase beta_K33D_mutation Human genes 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
102220354123 c.136C>A Human genes 0.000 description 8
229960005091 chloramphenicol Drugs 0.000 description 8
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 8
230000007812 deficiency Effects 0.000 description 8
IGMNYECMUMZDDF-UHFFFAOYSA-N homogentisic acid Chemical compound OC(=O)CC1=CC(O)=CC=C1O IGMNYECMUMZDDF-UHFFFAOYSA-N 0.000 description 8
125000003729 nucleotide group Chemical group 0.000 description 8
230000001105 regulatory effect Effects 0.000 description 8
102220216328 rs1060501891 Human genes 0.000 description 8
102220021057 rs397508897 Human genes 0.000 description 8
108010065511 Amylases Proteins 0.000 description 7
102000013142 Amylases Human genes 0.000 description 7
240000006439 Aspergillus oryzae Species 0.000 description 7
235000002247 Aspergillus oryzae Nutrition 0.000 description 7
102220527418 Calcium-activated potassium channel subunit beta-4_T11D_mutation Human genes 0.000 description 7
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
102220531652 WW domain-containing adapter protein with coiled-coil_F14S_mutation Human genes 0.000 description 7
235000019418 amylase Nutrition 0.000 description 7
229910052799 carbon Inorganic materials 0.000 description 7
238000012512 characterization method Methods 0.000 description 7
230000002538 fungal effect Effects 0.000 description 7
239000000499 gel Substances 0.000 description 7
239000008103 glucose Substances 0.000 description 7
239000000463 material Substances 0.000 description 7
230000004048 modification Effects 0.000 description 7
238000012986 modification Methods 0.000 description 7
239000002773 nucleotide Substances 0.000 description 7
239000013612 plasmid Substances 0.000 description 7
230000002797 proteolythic effect Effects 0.000 description 7
102220001770 rs137852957 Human genes 0.000 description 7
102200027492 rs63750285 Human genes 0.000 description 7
235000002639 sodium chloride Nutrition 0.000 description 7
239000004382 Amylase Substances 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
238000007792 addition Methods 0.000 description 6
230000001580 bacterial effect Effects 0.000 description 6
230000035772 mutation Effects 0.000 description 6
239000008188 pellet Substances 0.000 description 6
230000008488 polyadenylation Effects 0.000 description 6
239000000126 substance Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
241000228245 Aspergillus niger Species 0.000 description 5
101000757144 Aspergillus niger Glucoamylase Proteins 0.000 description 5
QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 5
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
108030003031 Tyrosine ammonia-lyases Proteins 0.000 description 5
230000001186 cumulative effect Effects 0.000 description 5
238000004128 high performance liquid chromatography Methods 0.000 description 5
238000011068 loading method Methods 0.000 description 5
229920000642 polymer Polymers 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
201000007972 tyrosinemia type I Diseases 0.000 description 5
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
241000351920 Aspergillus nidulans Species 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
108700007698 Genetic Terminator Regions Proteins 0.000 description 4
102000030789 Histidine Ammonia-Lyase Human genes 0.000 description 4
108700006308 Histidine ammonia-lyases Proteins 0.000 description 4
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
102220642375 Lysosomal alpha-mannosidase_K95R_mutation Human genes 0.000 description 4
SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Chemical compound OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 4
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 4
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 4
108010093965 Polymyxin B Proteins 0.000 description 4
102220472177 Thymidine kinase 2, mitochondrial_T17V_mutation Human genes 0.000 description 4
229960003767 alanine Drugs 0.000 description 4
108090000637 alpha-Amylases Proteins 0.000 description 4
102000004139 alpha-Amylases Human genes 0.000 description 4
229940024171 alpha-amylase Drugs 0.000 description 4
230000015556 catabolic process Effects 0.000 description 4
230000008859 change Effects 0.000 description 4
235000015872 dietary supplement Nutrition 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
239000001963 growth medium Substances 0.000 description 4
230000006872 improvement Effects 0.000 description 4
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
229960003136 leucine Drugs 0.000 description 4
239000002609 medium Substances 0.000 description 4
229960003548 polymyxin b sulfate Drugs 0.000 description 4
230000004044 response Effects 0.000 description 4
102220214816 rs41294988 Human genes 0.000 description 4
102220095438 rs876658180 Human genes 0.000 description 4
239000002904 solvent Substances 0.000 description 4
238000012289 standard assay Methods 0.000 description 4
238000013519 translation Methods 0.000 description 4
201000007962 tyrosinemia type II Diseases 0.000 description 4
238000005406 washing Methods 0.000 description 4
102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 3
101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 description 3
108010037870 Anthranilate Synthase Proteins 0.000 description 3
102000004580 Aspartic Acid Proteases Human genes 0.000 description 3
108010017640 Aspartic Acid Proteases Proteins 0.000 description 3
241000193830 Bacillus <bacterium> Species 0.000 description 3
244000063299 Bacillus subtilis Species 0.000 description 3
235000014469 Bacillus subtilis Nutrition 0.000 description 3
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 3
241000223221 Fusarium oxysporum Species 0.000 description 3
102220541624 HLA class II histocompatibility antigen, DQ beta 1 chain_Y41L_mutation Human genes 0.000 description 3
102100027612 Kallikrein-11 Human genes 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
108010014251 Muramidase Proteins 0.000 description 3
102000016943 Muramidase Human genes 0.000 description 3
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
241000235403 Rhizomucor miehei Species 0.000 description 3
101710152431 Trypsin-like protease Proteins 0.000 description 3
208000032001 Tyrosinemia type 1 Diseases 0.000 description 3
208000035169 Tyrosinemia type 2 Diseases 0.000 description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
206010047700 Vomiting Diseases 0.000 description 3
IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 3
238000009825 accumulation Methods 0.000 description 3
108010048241 acetamidase Proteins 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
238000004587 chromatography analysis Methods 0.000 description 3
239000003814 drug Substances 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
229960000274 lysozyme Drugs 0.000 description 3
239000004325 lysozyme Substances 0.000 description 3
235000010335 lysozyme Nutrition 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
239000002777 nucleoside Substances 0.000 description 3
125000003835 nucleoside group Chemical group 0.000 description 3
230000037361 pathway Effects 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
230000004481 post-translational protein modification Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
230000008569 process Effects 0.000 description 3
235000019833 protease Nutrition 0.000 description 3
238000003259 recombinant expression Methods 0.000 description 3
238000011160 research Methods 0.000 description 3
102200131349 rs60446065 Human genes 0.000 description 3
102220264101 rs748090667 Human genes 0.000 description 3
102220076193 rs772617064 Human genes 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
201000007971 tyrosinemia type III Diseases 0.000 description 3
210000002700 urine Anatomy 0.000 description 3
230000008673 vomiting Effects 0.000 description 3
WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 2
102220543795 39S ribosomal protein L15, mitochondrial_P29L_mutation Human genes 0.000 description 2
NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
VDABVNMGKGUPEY-UHFFFAOYSA-N 6-carboxyfluorescein succinimidyl ester Chemical compound C=1C(O)=CC=C2C=1OC1=CC(O)=CC=C1C2(C1=C2)OC(=O)C1=CC=C2C(=O)ON1C(=O)CCC1=O VDABVNMGKGUPEY-UHFFFAOYSA-N 0.000 description 2
102220578235 ATP-dependent Clp protease proteolytic subunit, mitochondrial_L93Q_mutation Human genes 0.000 description 2
102000004400 Aminopeptidases Human genes 0.000 description 2
108090000915 Aminopeptidases Proteins 0.000 description 2
239000004475 Arginine Substances 0.000 description 2
102000000050 Aromatic amino acid lyases Human genes 0.000 description 2
108050008359 Aromatic amino acid lyases Proteins 0.000 description 2
101000690713 Aspergillus niger Alpha-glucosidase Proteins 0.000 description 2
108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
108090000087 Carboxypeptidase B Proteins 0.000 description 2
102000003670 Carboxypeptidase B Human genes 0.000 description 2
102000000496 Carboxypeptidases A Human genes 0.000 description 2
108010080937 Carboxypeptidases A Proteins 0.000 description 2
241000048285 Chroogloeocystis siderophila Species 0.000 description 2
WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
108700010070 Codon Usage Proteins 0.000 description 2
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
206010012559 Developmental delay Diseases 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
102220485980 Dihydropteridine reductase_Q66R_mutation Human genes 0.000 description 2
102000004860 Dipeptidases Human genes 0.000 description 2
108090001081 Dipeptidases Proteins 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
108010013369 Enteropeptidase Proteins 0.000 description 2
102100029727 Enteropeptidase Human genes 0.000 description 2
102000010911 Enzyme Precursors Human genes 0.000 description 2
108010062466 Enzyme Precursors Proteins 0.000 description 2
241000605108 Flavobacterium johnsoniae Species 0.000 description 2
102000048120 Galactokinases Human genes 0.000 description 2
108700023157 Galactokinases Proteins 0.000 description 2
241000193385 Geobacillus stearothermophilus Species 0.000 description 2
101100369308 Geobacillus stearothermophilus nprS gene Proteins 0.000 description 2
101100080316 Geobacillus stearothermophilus nprT gene Proteins 0.000 description 2
102220563846 Glucagon receptor_K13S_mutation Human genes 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
206010019663 Hepatic failure Diseases 0.000 description 2
206010019842 Hepatomegaly Diseases 0.000 description 2
102000004157 Hydrolases Human genes 0.000 description 2
108090000604 Hydrolases Proteins 0.000 description 2
201000006347 Intellectual Disability Diseases 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
239000006142 Luria-Bertani Agar Substances 0.000 description 2
229930195725 Mannitol Natural products 0.000 description 2
XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
108090000284 Pepsin A Proteins 0.000 description 2
102000057297 Pepsin A Human genes 0.000 description 2
239000004695 Polyether sulfone Substances 0.000 description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
206010037660 Pyrexia Diseases 0.000 description 2
241000223253 Rhodotorula glutinis Species 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
206010041660 Splenomegaly Diseases 0.000 description 2
241001464991 Stanieria cyanosphaera Species 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 2
108700015934 Triose-phosphate isomerases Proteins 0.000 description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
208000034027 Tyrosinemia type 3 Diseases 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
239000008186 active pharmaceutical agent Substances 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
238000003149 assay kit Methods 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
238000012219 cassette mutagenesis Methods 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
229930016911 cinnamic acid Natural products 0.000 description 2
235000013985 cinnamic acid Nutrition 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
239000000356 contaminant Substances 0.000 description 2
239000013078 crystal Substances 0.000 description 2
239000005549 deoxyribonucleoside Substances 0.000 description 2
238000001514 detection method Methods 0.000 description 2
230000000378 dietary effect Effects 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
229910000397 disodium phosphate Inorganic materials 0.000 description 2
235000019800 disodium phosphate Nutrition 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000000975 dye Substances 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
206010016165 failure to thrive Diseases 0.000 description 2
238000001914 filtration Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 2
230000013595 glycosylation Effects 0.000 description 2
238000006206 glycosylation reaction Methods 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
230000028993 immune response Effects 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
239000007943 implant Substances 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
208000017169 kidney disease Diseases 0.000 description 2
201000006370 kidney failure Diseases 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
239000002502 liposome Substances 0.000 description 2
208000007903 liver failure Diseases 0.000 description 2
239000012139 lysis buffer Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000000594 mannitol Substances 0.000 description 2
235000010355 mannitol Nutrition 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
229940111202 pepsin Drugs 0.000 description 2
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
150000008300 phosphoramidites Chemical class 0.000 description 2
ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
238000007747 plating Methods 0.000 description 2
229920006393 polyether sulfone Polymers 0.000 description 2
230000001124 posttranscriptional effect Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
239000002342 ribonucleoside Substances 0.000 description 2
102220045535 rs587782187 Human genes 0.000 description 2
102200103632 rs71428908 Human genes 0.000 description 2
102220128472 rs766082334 Human genes 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
238000002864 sequence alignment Methods 0.000 description 2
239000002002 slurry Substances 0.000 description 2
UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
238000010189 synthetic method Methods 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000001890 transfection Methods 0.000 description 2
230000014616 translation Effects 0.000 description 2
229960001322 trypsin Drugs 0.000 description 2
239000004474 valine Substances 0.000 description 2
229960004295 valine Drugs 0.000 description 2
238000005303 weighing Methods 0.000 description 2
210000005253 yeast cell Anatomy 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
102100028626 4-hydroxyphenylpyruvate dioxygenase Human genes 0.000 description 1
108030005241 4-hydroxyphenylpyruvate oxidases Proteins 0.000 description 1
101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
206010001014 Acute polyneuropathies Diseases 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
208000033399 Anaphylactic responses Diseases 0.000 description 1
241000534414 Anotopterus nikparini Species 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
101000961203 Aspergillus awamori Glucoamylase Proteins 0.000 description 1
101900127796 Aspergillus oryzae Glucoamylase Proteins 0.000 description 1
101900318521 Aspergillus oryzae Triosephosphate isomerase Proteins 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
206010003591 Ataxia Diseases 0.000 description 1
108090000145 Bacillolysin Proteins 0.000 description 1
101000775727 Bacillus amyloliquefaciens Alpha-amylase Proteins 0.000 description 1
241000194108 Bacillus licheniformis Species 0.000 description 1
101000695691 Bacillus licheniformis Beta-lactamase Proteins 0.000 description 1
108010045681 Bacillus stearothermophilus neutral protease Proteins 0.000 description 1
101900040182 Bacillus subtilis Levansucrase Proteins 0.000 description 1
108091005658 Basic proteases Proteins 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
102100030981 Beta-alanine-activating enzyme Human genes 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
108010059892 Cellulase Proteins 0.000 description 1
108010084185 Cellulases Proteins 0.000 description 1
102000005575 Cellulases Human genes 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
208000034656 Contusions Diseases 0.000 description 1
206010010904 Convulsion Diseases 0.000 description 1
101710199851 Copy number protein Proteins 0.000 description 1
MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
244000303965 Cyamopsis psoralioides Species 0.000 description 1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
102000018832 Cytochromes Human genes 0.000 description 1
108010052832 Cytochromes Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
150000008574 D-amino acids Chemical group 0.000 description 1
NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
101710088194 Dehydrogenase Proteins 0.000 description 1
101100342470 Dictyostelium discoideum pkbA gene Proteins 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
102220568464 Dual specificity mitogen-activated protein kinase kinase 1_T17P_mutation Human genes 0.000 description 1
108700036505 EC 4.3.1.5 Proteins 0.000 description 1
101150015836 ENO1 gene Proteins 0.000 description 1
208000010334 End Stage Liver Disease Diseases 0.000 description 1
206010015150 Erythema Diseases 0.000 description 1
101100385973 Escherichia coli (strain K12) cycA gene Proteins 0.000 description 1
241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
206010015958 Eye pain Diseases 0.000 description 1
101150094145 FAH gene Proteins 0.000 description 1
201000006328 Fanconi syndrome Diseases 0.000 description 1
241000233866 Fungi Species 0.000 description 1
101150108358 GLAA gene Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
101150009006 HIS3 gene Proteins 0.000 description 1
101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
101150028128 Hgd gene Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000773364 Homo sapiens Beta-alanine-activating enzyme Proteins 0.000 description 1
102100034782 Homogentisate 1,2-dioxygenase Human genes 0.000 description 1
108700023439 Homogentisate 1,2-dioxygenases Proteins 0.000 description 1
101150004132 Hpd gene Proteins 0.000 description 1
241001480714 Humicola insolens Species 0.000 description 1
206010020649 Hyperkeratosis Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
208000026156 Hypertyrosinemia Diseases 0.000 description 1
241001562081 Ikeda Species 0.000 description 1
102220539945 Ileal sodium/bile acid cotransporter_T11K_mutation Human genes 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
206010062018 Inborn error of metabolism Diseases 0.000 description 1
206010022998 Irritability Diseases 0.000 description 1
206010023126 Jaundice Diseases 0.000 description 1
208000001126 Keratosis Diseases 0.000 description 1
241000235058 Komagataella pastoris Species 0.000 description 1
SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
108010029541 Laccase Proteins 0.000 description 1
108010059881 Lactase Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
206010024264 Lethargy Diseases 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
102220571932 Lipase member M_P29A_mutation Human genes 0.000 description 1
239000006137 Luria-Bertani broth Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
101150068888 MET3 gene Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
101100022915 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cys-11 gene Proteins 0.000 description 1
108090000913 Nitrate Reductases Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
102220497096 Orexin/Hypocretin receptor type 1_K28G_mutation Human genes 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 1
108700006307 Ornithine carbamoyltransferases Proteins 0.000 description 1
102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 1
108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
206010033425 Pain in extremity Diseases 0.000 description 1
108010019160 Pancreatin Proteins 0.000 description 1
206010034133 Pathogen resistance Diseases 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
206010034960 Photophobia Diseases 0.000 description 1
102220644293 Prelamin-A/C_T24S_mutation Human genes 0.000 description 1
208000005107 Premature Birth Diseases 0.000 description 1
206010036590 Premature baby Diseases 0.000 description 1
102220471762 Proteasome subunit alpha type-7_K28A_mutation Human genes 0.000 description 1
102220493431 Putative uncharacterized protein encoded by MIR7-3HG_K28N_mutation Human genes 0.000 description 1
208000035977 Rare disease Diseases 0.000 description 1
241000700159 Rattus Species 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
108020005091 Replication Origin Proteins 0.000 description 1
208000004756 Respiratory Insufficiency Diseases 0.000 description 1
101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 1
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
101900354623 Saccharomyces cerevisiae Galactokinase Proteins 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
101100022918 Schizosaccharomyces pombe (strain 972 / ATCC 24843) sua1 gene Proteins 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
102220563280 Signal transducer and activator of transcription 2_Q66H_mutation Human genes 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
102220556469 Sodium/calcium exchanger 1_I74A_mutation Human genes 0.000 description 1
244000061456 Solanum tuberosum Species 0.000 description 1
235000002595 Solanum tuberosum Nutrition 0.000 description 1
241000256248 Spodoptera Species 0.000 description 1
241001464990 Stanieria Species 0.000 description 1
101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
241000187432 Streptomyces coelicolor Species 0.000 description 1
101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 1
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
108090000787 Subtilisin Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
108700005078 Synthetic Genes Proteins 0.000 description 1
230000006044 T cell activation Effects 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
241000223258 Thermomyces lanuginosus Species 0.000 description 1
101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
108090000340 Transaminases Proteins 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
102220483598 Troponin I, cardiac muscle_Y41H_mutation Human genes 0.000 description 1
102000016540 Tyrosine aminotransferases Human genes 0.000 description 1
108010042606 Tyrosine transaminase Proteins 0.000 description 1
102220482858 UAP56-interacting factor_Y41A_mutation Human genes 0.000 description 1
101150050575 URA3 gene Proteins 0.000 description 1
241000607291 Vibrio fluvialis Species 0.000 description 1
241000700605 Viruses Species 0.000 description 1
206010047623 Vitamin C deficiency Diseases 0.000 description 1
102220580678 Voltage-dependent T-type calcium channel subunit alpha-1H_R46A_mutation Human genes 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
108010045649 agarase Proteins 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
208000012759 altered mental status Diseases 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
230000036783 anaphylactic response Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000010171 animal model Methods 0.000 description 1
229940069428 antacid Drugs 0.000 description 1
239000003159 antacid agent Substances 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
101150009206 aprE gene Proteins 0.000 description 1
101150008194 argB gene Proteins 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
210000004507 artificial chromosome Anatomy 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229940009098 aspartate Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000003139 biocide Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000036983 biotransformation Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
230000036765 blood level Effects 0.000 description 1
208000027503 bloody stool Diseases 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
208000034526 bruise Diseases 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
102220370207 c.110A>G Human genes 0.000 description 1
102220359541 c.284C>T Human genes 0.000 description 1
102220481134 cAMP-dependent protein kinase catalytic subunit beta_K13Q_mutation Human genes 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229940106157 cellulase Drugs 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000015218 chewing gum Nutrition 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
208000011444 chronic liver failure Diseases 0.000 description 1
208000019425 cirrhosis of liver Diseases 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
238000004040 coloring Methods 0.000 description 1
238000004590 computer program Methods 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
238000005100 correlation spectroscopy Methods 0.000 description 1
WBCMGDNFDRNGGZ-ACNVUDSMSA-N coumarate Natural products COC(=O)C1=CO[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]3[C@@H]1C=C[C@]34OC(=O)C(=C4)[C@H](C)OC(=O)C=Cc5ccc(O)cc5 WBCMGDNFDRNGGZ-ACNVUDSMSA-N 0.000 description 1
239000006071 cream Substances 0.000 description 1
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
101150005799 dagA gene Proteins 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
230000001934 delay Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
235000007882 dietary composition Nutrition 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
238000007865 diluting Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000008298 dragée Substances 0.000 description 1
238000002296 dynamic light scattering Methods 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical compound C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 description 1
229960004770 esomeprazole Drugs 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
201000004356 excessive tearing Diseases 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
230000004927 fusion Effects 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
229940029575 guanosine Drugs 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
208000035861 hematochezia Diseases 0.000 description 1
230000002440 hepatic effect Effects 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
239000004009 herbicide Substances 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
108010002685 hygromycin-B kinase Proteins 0.000 description 1
206010020871 hypertrophic cardiomyopathy Diseases 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
208000016245 inborn errors of metabolism Diseases 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
239000001573 invertase Substances 0.000 description 1
235000011073 invertase Nutrition 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
229940116108 lactase Drugs 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000002429 large intestine Anatomy 0.000 description 1
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
239000000865 liniment Substances 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
201000007270 liver cancer Diseases 0.000 description 1
231100000835 liver failure Toxicity 0.000 description 1
208000014018 liver neoplasm Diseases 0.000 description 1
244000144972 livestock Species 0.000 description 1
208000018773 low birth weight Diseases 0.000 description 1
231100000533 low birth weight Toxicity 0.000 description 1
235000020905 low-protein-diet Nutrition 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
101150039489 lysZ gene Proteins 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000007721 medicinal effect Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000036630 mental development Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
231100000219 mutagenic Toxicity 0.000 description 1
230000003505 mutagenic effect Effects 0.000 description 1
239000002088 nanocapsule Substances 0.000 description 1
239000002086 nanomaterial Substances 0.000 description 1
239000002071 nanotube Substances 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
101150095344 niaD gene Proteins 0.000 description 1
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
235000021590 normal diet Nutrition 0.000 description 1
101150105920 npr gene Proteins 0.000 description 1
101150017837 nprM gene Proteins 0.000 description 1
239000002674 ointment Substances 0.000 description 1
229960000381 omeprazole Drugs 0.000 description 1
239000008203 oral pharmaceutical composition Substances 0.000 description 1
229940039219 orfadin Drugs 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
108090000021 oryzin Proteins 0.000 description 1
239000003973 paint Substances 0.000 description 1
238000002638 palliative care Methods 0.000 description 1
229940055695 pancreatin Drugs 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
239000006072 paste Substances 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000006320 pegylation Effects 0.000 description 1
101150019841 penP gene Proteins 0.000 description 1
JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000013641 positive control Substances 0.000 description 1
239000004331 potassium propionate Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
230000004845 protein aggregation Effects 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
101150108007 prs gene Proteins 0.000 description 1
101150086435 prs1 gene Proteins 0.000 description 1
101150070305 prsA gene Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
210000001187 pylorus Anatomy 0.000 description 1
101150054232 pyrG gene Proteins 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
201000004193 respiratory failure Diseases 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
208000007442 rickets Diseases 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
102220261077 rs1012113887 Human genes 0.000 description 1
102200139266 rs10490924 Human genes 0.000 description 1
102220075111 rs147516123 Human genes 0.000 description 1
102220066126 rs202130417 Human genes 0.000 description 1
102200004779 rs2232775 Human genes 0.000 description 1
102220223523 rs764312409 Human genes 0.000 description 1
102220285547 rs777948908 Human genes 0.000 description 1
102220257244 rs78349078 Human genes 0.000 description 1
102220062975 rs786204422 Human genes 0.000 description 1
102200117731 rs796051888 Human genes 0.000 description 1
102220095971 rs876658611 Human genes 0.000 description 1
101150025220 sacB gene Proteins 0.000 description 1
238000005185 salting out Methods 0.000 description 1
238000009738 saturating Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
208000010233 scurvy Diseases 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
230000006128 skin development Effects 0.000 description 1
206010040882 skin lesion Diseases 0.000 description 1
231100000444 skin lesion Toxicity 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
238000000527 sonication Methods 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
108010034333 spleen fibrinolytic proteinase (human) Proteins 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
101150106193 tal gene Proteins 0.000 description 1
108700004027 tat Genes Proteins 0.000 description 1
101150098170 tat gene Proteins 0.000 description 1
QIQCZROILFZKAT-UHFFFAOYSA-N tetracarbon dioxide Chemical group O=C=C=C=C=O QIQCZROILFZKAT-UHFFFAOYSA-N 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
235000010487 tragacanth Nutrition 0.000 description 1
239000000196 tragacanth Substances 0.000 description 1
229940116362 tragacanth Drugs 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
101150016309 trpC gene Proteins 0.000 description 1
108010034272 tyrase Proteins 0.000 description 1
150000003667 tyrosine derivatives Chemical class 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
239000011653 vitamin D2 Substances 0.000 description 1
MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
235000001892 vitamin D2 Nutrition 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
101150110790 xylB gene Proteins 0.000 description 1